MindBio Therapeutics Corp
CNSX:MBIO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
MindBio Therapeutics Corp
CNSX:MBIO
|
CA |
|
O
|
Origin Energy Ltd
XMUN:ORL
|
AU |
|
O
|
OliX Pharmaceuticals Inc
KOSDAQ:226950
|
KR |
|
L
|
L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA
F:AILA
|
FR |
|
Y
|
Yamaha Corp
F:YHA
|
JP |
|
Bank Ina Perdana Tbk PT
IDX:BINA
|
ID |
|
Suedwestdeutsche Salzwerke AG
F:SSH
|
DE |
|
A
|
Ackermans & Van Haaren NV
DUS:B3K
|
BE |
|
S
|
Sumitomo Metal Mining Co Ltd
F:S19
|
JP |
|
ForFarmers NV
AEX:FFARM
|
NL |
|
Radware Ltd
NASDAQ:RDWR
|
IL |
|
Brave Bison Group PLC
F:RT70
|
UK |
|
First Pacific Co Ltd
F:FPC
|
HK |
|
E
|
Estee Lauder Companies Inc
VSE:ESLA
|
US |
|
A
|
Argosy Property Ltd
OTC:IGPYF
|
NZ |
|
Fevara PLC
LSE:FVA
|
UK |
|
A
|
Aurora Energy Metals Ltd
ASX:1AE
|
AU |
|
Africa Energy Corp
XTSX:AFE
|
CA |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for MindBio Therapeutics Corp.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What MindBio Therapeutics Does
Mindbio Therapeutics Corp. engages in developing psychedelic medicines to treat medical conditions such as depression, anxiety, PTSD, panic disorder, chronic pain and opiate addictions. The company is headquartered in Vancouver, British Columbia. The company went IPO on 2023-05-05. The firm is focused on creating novel and emerging treatments for mental health conditions and is conducting lysergic acid diethylamide (LSD)-microdosing human clinical trials.
- Headquarters
- Canada CA
- IPO date
- May 5, 2023